These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7554453)

  • 21. Delayed-type hypersensitivity is mediated by a sequence of two different T cell activities.
    Van Loveren H; Askenase PW
    J Immunol; 1984 Nov; 133(5):2397-401. PubMed ID: 6332849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of delayed-type hypersensitivity and interferon-gamma to Candida albicans and anti-hen-egg white lysozyme antibody as phenotypic markers of enhanced bovine immune response.
    Heriazon A; Yager JA; Sears W; Mallard BA
    Vet Immunol Immunopathol; 2009 May; 129(1-2):93-100. PubMed ID: 19155071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of specific T cell immunity in patients with prostate cancer by vaccination with PSA146-154 peptide.
    Perambakam S; Hallmeyer S; Reddy S; Mahmud N; Bressler L; DeChristopher P; Mahmud D; Nunez R; Sosman JA; Peace DJ
    Cancer Immunol Immunother; 2006 Sep; 55(9):1033-42. PubMed ID: 16283303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphocyte recruitment in delayed-type hypersensitivity. The role of IFN-gamma.
    Issekutz TB; Stoltz JM; vd Meide P
    J Immunol; 1988 May; 140(9):2989-93. PubMed ID: 3129506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cutaneous delayed-type hypersensitivity (DTH) in a multi-formulation comparator trial of the anti-falciparum malaria vaccine candidate RTS,S in rhesus macaques.
    Stewart VA; Walsh DS; McGrath SM; Kester KE; Cummings JF; Voss G; Delchambre M; Garçon N; Cohen JD; Heppner DG
    Vaccine; 2006 Oct; 24(42-43):6493-502. PubMed ID: 16911849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delayed-type hypersensitivity response is a predictor of peripheral blood T-cell immunity after HER-2/neu peptide immunization.
    Disis ML; Schiffman K; Gooley TA; McNeel DG; Rinn K; Knutson KL
    Clin Cancer Res; 2000 Apr; 6(4):1347-50. PubMed ID: 10778962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Desensitization. IV: Permeability changes during active and passive desensitization.
    Baba T; Yoshida T; Cohen S
    J Exp Pathol; 1984; 1(3):175-82. PubMed ID: 6599937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impairment of allograft tumor immunity by isotype-like suppression of antigen-specific T cell factors.
    Van Loveren H; De Weger RA; Garssen J; Los G; Askenase PW
    Transplantation; 1989 Mar; 47(3):504-12. PubMed ID: 2466354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delayed-type hypersensitivity in palmoplantar pustulosis: effect of cyclosporin A treatment on skin testing with recall antigens.
    Remitz A; Lauerma AI; Erkko P; Reitamo S
    Acta Derm Venereol; 1996 Jul; 76(4):310-3. PubMed ID: 8869692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Local adoptive transfer of skin delayed-type hypersensitivity initiated by a single T lymphocyte.
    Marchal G; Seman M; Milon G; Truffa-Bachi P; Zilberfarb V
    J Immunol; 1982 Sep; 129(3):954-8. PubMed ID: 6980927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dextran augments delayed-type hypersensitivity by interrupting one limb of the suppressor cascade.
    Battisto JR; Beckman K; Yen-Lieberman B
    J Immunol; 1985 Apr; 134(4):2131-8. PubMed ID: 2579128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tetanus toxoid as an antigen for delayed cutaneous hypersensitivity.
    Delafuente JC; Eisenberg JD; Hoelzer DR; Slavin RG
    JAMA; 1983 Jun; 249(23):3209-11. PubMed ID: 6343648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
    Vandepapelière P; Horsmans Y; Moris P; Van Mechelen M; Janssens M; Koutsoukos M; Van Belle P; Clement F; Hanon E; Wettendorff M; Garçon N; Leroux-Roels G
    Vaccine; 2008 Mar; 26(10):1375-86. PubMed ID: 18272264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dendritic cells and T cells transfer sensitization for delayed-type hypersensitivity after skin painting with contact sensitizer.
    Macatonia SE; Knight SC
    Immunology; 1989 Jan; 66(1):96-9. PubMed ID: 15493269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adoptive immunotherapy with IL-2 results in the loss of delayed-type hypersensitivity responses and the development of immediate hypersensitivity to recall antigens.
    Kradin RL; Kurnick JT; Preffer FI; Dubinett SM; Dickersin GR; Pinto C
    Clin Immunol Immunopathol; 1989 Feb; 50(2):184-95. PubMed ID: 2783665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delayed-type hypersensitivity.
    Luo Y; Dorf ME
    Curr Protoc Immunol; 2001 May; Chapter 4():Unit 4.5. PubMed ID: 18432796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of lymphokines in delayed-type hypersensitivity reactions.
    Geczy CL
    Springer Semin Immunopathol; 1984; 7(4):321-46. PubMed ID: 6395409
    [No Abstract]   [Full Text] [Related]  

  • 38. Influence of SLO4 on the leucocyte migration inhibiting factor and on the DTH response.
    Vanderhoven C; Douet M; Mitchell K; Page Y; Girard JP
    J Immunopharmacol; 1986; 8(1):117-23. PubMed ID: 3519780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibodies to guinea pig lymphokines. II. Suppression of delayed hypersensitivity reactions by a "second generation" goat antibody against guinea pig lymphokines.
    Geczy CL; Geczy AF; De Weck AL
    J Immunol; 1976 Jul; 117(1):66-72. PubMed ID: 1084371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T-T cell interaction in the in vitro induction of delayed-type hypersensitivity (DTH) responses: demonstration of vaccinia virus-reactive helper T cell activity involved in enhanced induction of DTH responses.
    Kosugi A; Takai Y; Ogata M; Fujiwara H; Hamaoka T
    J Leukoc Biol; 1985 May; 37(5):629-39. PubMed ID: 3156939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.